水杨酸钠

  • 基本信息
  • 制备方法及用途
  • 物化性质
  • 安全信息
  • 毒理性
  • MSDS
  • 海关数据
  • 结构与计算化学
  • 上游产品
  • 下游产品
  • 表征图谱

水杨酸钠 基本信息

中文名称:
水杨酸钠 
中文别名:
水杨酸钠;
柳酸钠;
水杨酸;
2-羟基苯甲酸单钠盐;
邻羟基苯甲酸钠 
英文名称:
Sodium salicylate
英文别名:
Sodium salicylate;
salisod;
clin;
magsalyl;
sodium 2-hydroxybenzoate;
diuretin;
aroall;
salicylic acid monosodium salt;
NASAL;
ardall;
salicylic acid sodium salt;
alysine;
kerosal;
nadisal 
CAS No.:
54-21-7
分 子 式:

C7H5NaO3

分 子 量:
160.1
精确分子量:
160.01400
PSA:
60.36000
MDL:
MFCD00002440
EINECS:
200-198-0
BRN:
3732792
InChI:
InChI=1/C7H6O3.Na/c8-6-4-2-1-3-5(6)7(9)10;/h1-4,8H,(H,9,10);/q;+1/p-1
危险品标志:

Xn:Harmful
 

风险术语:

R22;

安全术语:

26-36

分子结构式:
SDS:
查看

水杨酸钠 制备方法及用途

制备方法

1.将水杨酸和碳酸氢钠交叉加入蒸馏水中,温度保持60℃,并保持呈酸性状态,同时加入适量乙二胺四乙酸(EDTA)及保险粉。升温至85℃,反应半小时。将合格的反应液经过滤送入沸腾床,85℃干燥得水杨酸。2.将水杨酸于50℃下溶解于蒸馏水中,在搅拌下慢慢的用稀氢氧化钠中和至ph值5.4~5.8: 反应结束后脱色过滤,滤液清亮后,减压浓缩至浆状,冷却,过滤出结晶,干燥后即为成品。

合成制备方法

1.将水杨酸和碳酸氢钠交叉加入蒸馏水中,温度保持60℃,并保持呈酸性状态,同时加入适量乙二胺四乙酸(EDTA)及保险粉。升温至85℃,反应半小时。将合格的反应液经过滤送入沸腾床,85℃干燥得水杨酸。

2.将水杨酸于50℃下溶解于蒸馏水中,在搅拌下慢慢的用稀氢氧化钠中和至ph值5.4~5.8:

反应结束后脱色过滤,滤液清亮后,减压浓缩至浆状,冷却,过滤出结晶,干燥后即为成品。

用途简介

有机合成原料、防腐剂、测胃液中游离酸的试剂。解热镇痛药和抗风湿药。 用作分析试剂。也用于有机合成,医药、电子、仪表、冶金工业等

用途

1.有机合成原料、防腐剂、测胃液中游离酸的试剂。解热镇痛药和抗风湿药。2.用作分析试剂。也用于有机合成,医药、电子、仪表、冶金工业等

水杨酸钠 物化性质

外观与性状:
白色晶体
熔点:
>300 °C(lit.)
沸点:
336.3ºC at 760mmHg
闪点:
144.5ºC
水溶解性:
1000 g/L (20 ºC)
折射率:
1.435
存储条件/存储方法:

避光保存。

稳定性相关:

1.见光变粉红色。

其它信息:

1.       性状: 白色鳞片状结晶或粉末。无气味。见光后变为粉红色。

2.       密度(g/mL,25/4℃): 未确定

3.       相对蒸汽密度(g/mL,空气=1):未确定

4.       熔点(ºC):160~166

5.       沸点(ºC,常压):未确定

6.       沸点(ºC,5.2kPa):未确定

7.       折射率:未确定

8.       闪点(ºC):未确定

9.       比旋光度(º):未确定

10.    自燃点或引燃温度(ºC):未确定

11.    蒸气压(kPa,25ºC):未确定

12.    饱和蒸气压(kPa,60ºC):未确定

13.    燃烧热(KJ/mol):未确定

14.    临界温度(ºC):未确定

15.    临界压力(KPa):未确定

16.    油水(辛醇/水)分配系数的对数值:未确定

17.    爆炸上限(%,V/V):未确定

18.    爆炸下限(%,V/V):未确定

19.    溶解性:易溶于水、 乙醇、 甘油。几乎不溶于醚、 氯仿和苯。1g产品溶于0.9ml水、9.2ml乙醇、4ml甘油。水溶液呈微酸性,pH为5~6。

水杨酸钠 安全信息

海关代码:
2918211000
WGK_Germany:
1
德国有关水污染物质的分类清单
危险类别码:
R22
安全说明:
S26
RTECS号:
VO5075000
安全标志:
S26:万一接触眼睛,立即使用大量清水冲洗并送医诊治。
危险标志:
Xn:Harmful

水杨酸钠 毒理性

CHEMICAL IDENTIFICATION

RTECS NUMBER :
VO5075000
CHEMICAL NAME :
Salicylic acid, monosodium salt
CAS REGISTRY NUMBER :
54-21-7
LAST UPDATED :
199703
DATA ITEMS CITED :
69
MOLECULAR FORMULA :
C7-H5-O3.Na
MOLECULAR WEIGHT :
160.11
WISWESSER LINE NOTATION :
QVR BQ &-NA-

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Human
DOSE/DURATION :
700 mg/kg
TOXIC EFFECTS :
Behavioral - excitement Behavioral - muscle contraction or spasticity Lungs, Thorax, or Respiration - dyspnea
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Unreported
SPECIES OBSERVED :
Human - woman
DOSE/DURATION :
1400 mg/kg
TOXIC EFFECTS :
Behavioral - toxic psychosis Lungs, Thorax, or Respiration - respiratory stimulation Skin and Appendages - sweating
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Multiple routes
SPECIES OBSERVED :
Human - child
DOSE/DURATION :
2970 mg/kg/13D
TOXIC EFFECTS :
Behavioral - excitement Gastrointestinal - nausea or vomiting
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
930 mg/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold Behavioral - muscle contraction or spasticity
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
542 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
540 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
500 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
550 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
560 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intramuscular
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
760 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Mammal - dog
DOSE/DURATION :
450 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Mammal - dog
DOSE/DURATION :
990 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Mammal - dog
DOSE/DURATION :
200 mg/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold Lungs, Thorax, or Respiration - dyspnea Lungs, Thorax, or Respiration - other changes
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Mammal - dog
DOSE/DURATION :
562 mg/kg
TOXIC EFFECTS :
Behavioral - analgesia
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rabbit
DOSE/DURATION :
1700 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rabbit
DOSE/DURATION :
415 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - guinea pig
DOSE/DURATION :
900 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - guinea pig
DOSE/DURATION :
800 mg/kg
TOXIC EFFECTS :
Cardiac - arrhythmias (including changes in conduction) Behavioral - excitement Lungs, Thorax, or Respiration - dyspnea
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Amphibian - frog
DOSE/DURATION :
250 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
2100 mg/kg/7D-C
TOXIC EFFECTS :
Blood - changes in serum composition (e.g. TP, bilirubin, cholesterol)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
6600 mg/kg/11D-I
TOXIC EFFECTS :
Liver - other changes Kidney, Ureter, Bladder - changes in tubules (including acute renal failure, acute tubular necrosis) Related to Chronic Data - death
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
16350 mg/kg/15W-I
TOXIC EFFECTS :
Behavioral - muscle weakness Nutritional and Gross Metabolic - weight loss or decreased weight gain
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
18200 mg/kg/13W-C
TOXIC EFFECTS :
Liver - other changes Kidney, Ureter, Bladder - other changes Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - phosphatases
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
3360 mg/kg/14D-I
TOXIC EFFECTS :
Behavioral - fluid intake Kidney, Ureter, Bladder - urine volume increased Nutritional and Gross Metabolic - weight loss or decreased weight gain
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Mammal - dog
DOSE/DURATION :
3900 mg/kg/2W-I
TOXIC EFFECTS :
Kidney, Ureter, Bladder - changes in tubules (including acute renal failure, acute tubular necrosis)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
40 mg/kg
SEX/DURATION :
female 20-21 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Newborn - stillbirth
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
250 mg/kg
SEX/DURATION :
female 9 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants) Reproductive - Specific Developmental Abnormalities - other developmental abnormalities
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
250 mg/kg
SEX/DURATION :
female 9 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - musculoskeletal system
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
25 mg/kg
SEX/DURATION :
female 20-21 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Newborn - weaning or lactation index (e.g., # alive at weaning per # alive at day 4)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
375 mg/kg
SEX/DURATION :
female 8-10 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Newborn - behavioral
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
3 gm/kg
SEX/DURATION :
female 6-15 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - extra-embryonic structures (e.g., placenta, umbilical cord)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intraperitoneal
DOSE :
500 mg/kg
SEX/DURATION :
female 8 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants) Reproductive - Specific Developmental Abnormalities - musculoskeletal system
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intraperitoneal
DOSE :
849 mg/kg
SEX/DURATION :
female 9-11 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intraperitoneal
DOSE :
150 mg/kg
SEX/DURATION :
female 12-14 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetal death
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
300 mg/kg
SEX/DURATION :
female 9 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - musculoskeletal system Reproductive - Specific Developmental Abnormalities - Central Nervous System
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
50 mg/kg
SEX/DURATION :
female 21 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - cardiovascular (circulatory) system
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
400 mg/kg
SEX/DURATION :
female 10 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - eye/ear Reproductive - Specific Developmental Abnormalities - body wall
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
300 mg/kg
SEX/DURATION :
female 10 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravenous
DOSE :
600 mg/kg
SEX/DURATION :
female 6-13 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants) Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Parenteral
DOSE :
400 mg/kg
SEX/DURATION :
female 10 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetal death Reproductive - Specific Developmental Abnormalities - Central Nervous System Reproductive - Specific Developmental Abnormalities - craniofacial (including nose and tongue)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Unreported
DOSE :
400 mg/kg
SEX/DURATION :
female 10 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants) Reproductive - Specific Developmental Abnormalities - other developmental abnormalities
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
665 mg/kg
SEX/DURATION :
female 17 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetal death Reproductive - Effects on Embryo or Fetus - other effects to embryo Reproductive - Specific Developmental Abnormalities - other developmental abnormalities
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
4 gm/kg
SEX/DURATION :
female 8-12 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Newborn - growth statistics (e.g.%, reduced weight gain)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
2 gm/kg
SEX/DURATION :
female 8 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - musculoskeletal system
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
1500 mg/kg
SEX/DURATION :
female 7 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetal death Reproductive - Specific Developmental Abnormalities - musculoskeletal system
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
8 gm/kg
SEX/DURATION :
female 8-12 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Newborn - live birth index (measured after birth) Reproductive - Effects on Newborn - viability index (e.g., # alive at day 4 per # born alive)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intramuscular
DOSE :
400 mg/kg
SEX/DURATION :
female 12 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants) Reproductive - Specific Developmental Abnormalities - cardiovascular (circulatory) system
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intramuscular
DOSE :
400 mg/kg
SEX/DURATION :
female 9 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - musculoskeletal system
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intramuscular
DOSE :
500 mg/kg
SEX/DURATION :
female 17 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetal death Reproductive - Specific Developmental Abnormalities - other developmental abnormalities
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intramuscular
DOSE :
500 mg/kg
SEX/DURATION :
female 17 day(s) after conception
TOXIC EFFECTS :
Reproductive - Maternal Effects - parturition
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intraperitoneal
DOSE :
1100 mg/kg
SEX/DURATION :
female 8 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - Central Nervous System
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
125 mg/kg
SEX/DURATION :
female 18 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants) Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
250 mg/kg
SEX/DURATION :
female 18 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - musculoskeletal system
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
400 mg/kg
SEX/DURATION :
female 13 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - eye/ear Reproductive - Specific Developmental Abnormalities - craniofacial (including nose and tongue)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
125 mg/kg
SEX/DURATION :
female 18 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants)
TYPE OF TEST :
DNA damage
TYPE OF TEST :
Cytogenetic analysis

MUTATION DATA

TEST SYSTEM :
Rodent - mouse
DOSE/DURATION :
350 mg/kg
REFERENCE :
MUREAV Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964- Volume(issue)/page/year: 370,1,1996 *** REVIEWS *** TOXICOLOGY REVIEW PEDIAU Pediatrics. (American Academy of Pediatrics, P.O. Box 1034, Evanston, IL 60204) V.1- 1948- Volume(issue)/page/year: 54,342,1974 TOXICOLOGY REVIEW ARVPAX Annual Review of Pharmacology. (Palo Alto, CA) V.1-15, 1961-75. For publisher information, see ARPTDI. Volume(issue)/page/year: 5,447,1965 TOXICOLOGY REVIEW AJMEAZ American Journal of Medicine. (Technical Pub., 875 Third Ave., New York, NY 10022) V.1- 1946- Volume(issue)/page/year: 38,409,1965 TOXICOLOGY REVIEW ADVPA3 Advances in Pharmacology. (New York, NY) V.1-6, 1962-68. For publisher information, see AVPCAQ. Volume(issue)/page/year: 4,263,1966 TOXICOLOGY REVIEW 85DJA5 "Malformations Congenitales des Mammiferes," Tuchmann-Duplessis, H., Paris, Masson et Cie, 1971 Volume(issue)/page/year: -,171,1971 TOXICOLOGY REVIEW APSQA7 Acta Paediatrica Scandinavica, Supplement. (Almqvist & Wiksell International, POB 4627, S-11691 Stockholm, Sweden) No. 158-379 1965-91 Volume(issue)/page/year: (211),24,1971 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOHS - National Occupational Hazard Survey (1974) NOHS Hazard Code - 84407 No. of Facilities: 1892 (estimated) No. of Industries: 6 No. of Occupations: 16 No. of Employees: 16641 (estimated) NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - 84407 No. of Facilities: 2056 (estimated) No. of Industries: 9 No. of Occupations: 18 No. of Employees: 29395 (estimated) No. of Female Employees: 19141 (estimated)
毒理学数据:

 

水杨酸钠 MSDS

第一部分:化学品名称
化学品中文名称: 水杨酸钠;邻羟基苯甲酸钠
化学品英文名称: Sodium salicylate;Sodium o-hydroxybenzoate
中文俗名或商品名:
Synonyms:
CAS No.: 54-21-7
分子式: C7H5NaO3
分子量: 160.11
第二部分:成分/组成信息
             纯化学品   混合物
             化学品名称:水杨酸钠;邻羟基苯甲酸钠
有害物成分 含量 CAS No.
第三部分:危险性概述
危险性类别:
侵入途径: 吸入 食入 经皮吸收
健康危害: 对眼睛、皮肤、粘膜和上呼吸道有刺激作用。刺激消化道,引起食欲不振、恶心、呕吐,严重时可致消化道出血,并能诱发和加重胃溃疡;也可引起头痛、眩晕、耳鸣、视力减退、过敏反应等。
环境危害:
燃爆危险: 本品可燃,具刺激性。
第四部分:急救措施
皮肤接触: 用肥皂水及清水彻底冲洗。就医。
眼睛接触: 拉开眼睑,用流动清水冲洗15分钟。就医。
吸入: 脱离现场至空气新鲜处。就医。
食入: 误服者,饮适量温水,催吐。就医。
第五部分:消防措施
危险特性: 遇明火、高热可燃。受高热分解,放出有毒的烟气。
有害燃烧产物: 一氧化碳、二氧化碳、氧化钠。
灭火方法及灭火剂: 消防人员须佩戴防毒面具、穿全身消防服,在上风向灭火。切勿将水流直接射至熔融物,以免引起严重的流淌火灾或引起剧烈的沸溅。灭火剂:泡沫、二氧化碳、干粉、砂土。
消防员的个体防护:
禁止使用的灭火剂:
闪点(℃):
自燃温度(℃):
爆炸下限[%(V/V)]:
爆炸上限[%(V/V)]:
最小点火能(mJ):
爆燃点:
爆速:
最大燃爆压力(MPa):
建规火险分级:
第六部分:泄漏应急处理
应急处理: 隔离泄漏污染区,周围设警告标志,建议应急处理人员戴好防毒面具,穿化学防护服。用大量水冲洗,经稀释的污水放入废水系统。也可以小心扫起,避免扬尘,收集运至废物处理场所。如大量泄漏,收集回收或无害处理后废弃。
第七部分:操作处置与储存
操作注意事项: 密闭操作,局部排风。防止粉尘释放到车间空气中。操作人员必须经过专门培训,严格遵守操作规程。建议操作人员佩戴自吸过滤式防尘口罩,戴化学安全防护眼镜,穿防毒物渗透工作服,戴橡胶手套。远离火种、热源,工作场所严禁吸烟。使用防爆型的通风系统和设备。避免产生粉尘。避免与氧化剂、碱类接触。配备相应品种和数量的消防器材及泄漏应急处理设备。倒空的容器可能残留有害物。
储存注意事项: 储存于阴凉、通风的库房。远离火种、热源。防止阳光直射。包装密封。应与氧化剂、碱类分开存放,切忌混储。配备相应品种和数量的消防器材。储区应备有合适的材料收容泄漏物。
第八部分:接触控制/个体防护
最高容许浓度: 中 国 MAC:未制订标准前苏联 MAC:未制订标准美国TLV—TWA:未制订标准
监测方法:
工程控制: 密闭操作,局部排风。
呼吸系统防护: 佩戴防尘口罩。空气中浓度较高时,建议佩戴防毒面具。
眼睛防护: 戴化学安全防护眼镜。
身体防护: 穿相应的防护服。
手防护: 戴防化学品手套。
其他防护: 工作后,淋浴更衣。保持良好的卫生习惯。
第九部分:理化特性
外观与性状: 白色鳞片或粉末,无气味,久露光线中变粉红色。
pH:
熔点(℃): 200
沸点(℃):
相对密度(水=1):
相对蒸气密度(空气=1):
饱和蒸气压(kPa):
燃烧热(kJ/mol):
临界温度(℃):
临界压力(MPa):
辛醇/水分配系数的对数值:
闪点(℃):
引燃温度(℃):
爆炸上限%(V/V):
爆炸下限%(V/V):
分子式: C7H5NaO3
分子量: 160.11
蒸发速率:
粘性:
溶解性: 溶于水、甘油,不溶于醚、氯仿、苯。
主要用途: 作解热、镇痛药,分析试剂,防腐剂。
第十部分:稳定性和反应活性
稳定性: 在常温常压下 稳定
禁配物: 强氧化剂、强酸。
避免接触的条件: 光照。
聚合危害: 不能出现
分解产物: 一氧化碳、二氧化碳、氧化钠。
第十一部分:毒理学资料
急性毒性: LD50:1200mg/kg(大鼠经口) LC50:
急性中毒:
慢性中毒:
亚急性和慢性毒性:
刺激性:
致敏性:
致突变性:
致畸性:
致癌性:
第十二部分:生态学资料
生态毒理毒性:
生物降解性:
非生物降解性:
生物富集或生物积累性:
第十三部分:废弃处置
废弃物性质:
废弃处置方法: 建议用焚烧法处置。在能利用的地方重复使用容器或在规定场所掩埋。
废弃注意事项:
第十四部分:运输信息
危险货物编号:
UN编号:
包装标志:
包装类别:
包装方法:
运输注意事项: 储存于阴凉、通风仓间内。远离火种、热源。包装密封。避光保存。应与氧化剂、酸类、食用化工原料分开存放。搬运时轻装轻卸,保持包装完整,防止泄漏。分装和搬运作业要注意个人防护。
RETCS号:
IMDG规则页码:
第十五部分:法规信息
国内化学品安全管理法规: 化学危险物品安全管理条例 (1987年2月17日国务院发布),化学危险物品安全管理条例实施细则 (化劳发[1992] 677号),工作场所安全使用化学品规定 ([1996]劳部发423号)等法规,针对化学危险品的安全使用、生产、储存、运输、装卸等方面均作了相应规定。
国际化学品安全管理法规:
第十六部分:其他信息
参考文献: 1.周国泰,化学危险品安全技术全书,化学工业出版社,1997 2.国家环保局有毒化学品管理办公室、北京化工研究院合编,化学品毒性法规环境数据手册,中国环境科学出版社.1992 3.Canadian Centre for Occupational Health and Safety,CHEMINFO Database.1998 4.Canadian Centre for Occupational Health and Safety, RTECS Database, 1989
填表时间: 年月日
填表部门:
数据审核单位:
修改说明:
其他信息: 6
MSDS修改日期: 年月日

水杨酸钠 海关数据

中国海关编码:2918211000

概述:
2918211000. 水杨酸、水杨酸钠. 增值税率:17.0%. 退税率:9.0%. 监管条件:无. 最低关税:6.5%. 普通关税:20.0%
申报要素:
品名, 成分含量, 用途
摘要/Summary:
2918211000. VAT:17.0%. Tax rebate rate:9.0%. . MFN tariff:6.5%. General tariff:20.0%

水杨酸钠 分子结构与计算化学数据

计算化学数据

1.疏水参数计算参考值(XlogP):无

2.氢键供体数量:1

3.氢键受体数量:3

4.可旋转化学键数量:1

5.互变异构体数量:4

6.拓扑分子极性表面积60.4

7.重原子数量:11

8.表面电荷:0

9.复杂度:138

10.同位素原子数量:0

11.确定原子立构中心数量:0

12.不确定原子立构中心数量:0

13.确定化学键立构中心数量:0

14.不确定化学键立构中心数量:0

15.共价键单元数量:2

推荐供应商更多供应商>>

湖北诺纳科技有限公司

产品介绍:
产品名称:水杨酸钠 Cas号:54-21-7 纯度:99% 包装信息:1kg铝箔袋/氟化瓶,10kg铝听/纸箱,25kg纸板桶/编织袋/塑料桶 价格:1.0元 - 25.0元
联系方式:
联系人:张经理 电话:02759209883 手机:17386169806

武汉鑫伟烨化工有限公司

产品介绍:
产品名称:水杨酸钠 Cas号:54-21-7 纯度:98% 包装信息:25kg,25kg,25kg 价格:1.0元 - 1.0元
联系方式:
联系人:郭经理 电话:027-85953558 手机:13377862267

湖北威德利化学科技有限公司

产品介绍:
产品名称:水杨酸钠 Cas号:54-21-7 纯度:99.0%—100.5% 包装信息:25/纸板桶kg 价格:洽谈
联系方式:
联系人:魏兵 电话:027-83991220 手机:13657209475

湖北鑫鸣泰化学有限公司

产品介绍:
产品名称:水杨酸钠 Cas号:54-21-7 纯度:99% 包装信息:100kg,200kg 价格:1.0元 - 1.0元
联系方式:
联系人:黄 电话:027-50662354 手机:13264726139

湖北鑫鸣泰化学有限公司

产品介绍:
产品名称:水杨酸钠 Cas号:54-21-7 纯度:98% 包装信息:25/桶kg 价格:1.0元
联系方式:
联系人:黄经理 电话:027-51833411 手机:13237166274

湘潭 嘉叶源生物科技有限公司

产品介绍:
产品名称:水杨酸钠 Cas号:54-21-7 纯度:99 包装信息:500g,1g,25g,100g,500g 价格:1.0元 - 1.0元
联系方式:
联系人:刘 电话:15348325506 手机:15348325506

武汉市创署电子商务有限公司

产品介绍:
产品名称:水杨酸钠54-21-7厂家现货供应质优价廉 Cas号:54-21-7 纯度:99.5% 包装信息:25kg/牛皮纸袋 可拆分 件 价格:洽谈
联系方式:
联系人:杨经理 电话:18872220736 手机:18872220736

潍坊万诺化工有限公司

产品介绍:
产品名称:水杨酸钠 Cas号:54-21-7 纯度:99 包装信息:25纸板桶kg 价格:1.0元
联系方式:
联系人:何 电话:18975293290 手机:18975293290

泰安市嘉叶生物科技有限公司

产品介绍:
产品名称:水杨酸钠原粉 CAS:54-21-7山东厂家现货直销 Cas号:54-21-7 纯度:99 包装信息:25/复合编织袋kg 价格:洽谈
联系方式:
联系人:苏经理 电话:0538-6307626 手机:17753805870

武汉福德化工有限公司

产品介绍:
产品名称:水杨酸钠 Cas号:54-21-7 纯度: 包装信息:25kg 价格:洽谈
联系方式:
联系人:刘雅倩 电话:027-83855392 手机:15827396479